Common Community-acquired Infections and Subsequent Risk of Multiple Myeloma: a Population-based Study
Overview
Affiliations
The role of bacteria and viruses as aetiological agents in the pathogenesis of cancer has been well established for several sites, including a number of haematological malignancies. Less clear is the impact of such exposures on the subsequent development of multiple myeloma (MM). Using the population-based U.S. Surveillance Epidemiology and End Results-Medicare dataset, 15,318 elderly MM and 200,000 controls were identified to investigate the impact of 14 common community-acquired infections and risk of MM. Odds ratios (ORs) and associated 95% confidence intervals (CIs) were adjusted for sex, age and calendar year of selection. The 13-month period prior to diagnosis/selection was excluded. Risk of MM was increased by 5-39% following Medicare claims for eight of the investigated infections. Positive associations were observed for several infections including bronchitis (adjusted OR 1.14, 95% CI 1.09-1.18), sinusitis (OR 1.15, 95% CI 1.10-1.20) pneumonia (OR 1.27, 95% CI 1.21-1.33), herpes zoster (OR 1.39, 95% CI 1.29-1.49) and cystitis (OR 1.09, 95% CI 1.05-1.14). Each of these infections remained significantly elevated following the exclusion of more than 6 years of claims data. Exposure to infectious antigens may therefore play a role in the development of MM. Alternatively, the observed associations may be a manifestation of an underlying immune disturbance present several years prior to MM diagnosis and thereby part of the natural history of disease progression.
Microbiota-derived urolithin A in monoclonal gammopathies and multiple myeloma therapy.
Rodriguez-Garcia A, Ancos-Pintado R, Garcia-Vicente R, Ortiz-Ruiz A, Arroyo A, Navarro M Microbiome. 2025; 13(1):56.
PMID: 40022244 PMC: 11869585. DOI: 10.1186/s40168-025-02045-6.
Hermouet S, Bigot-Corbel E, Harb J Front Immunol. 2023; 14:1253363.
PMID: 38022528 PMC: 10644846. DOI: 10.3389/fimmu.2023.1253363.
Exploring the role of viral hepatitis in plasma cell disorders.
ODonnell E Haematologica. 2023; 109(1):19-20.
PMID: 37470153 PMC: 10772513. DOI: 10.3324/haematol.2023.283461.
Rodriguez-Garcia A, Mennesson N, Hernandez-Ibarburu G, Morales M, Garderet L, Bouchereau L Haematologica. 2023; 109(1):272-282.
PMID: 37199121 PMC: 10772493. DOI: 10.3324/haematol.2023.283096.
Editorial: The Role of Microorganisms in Multiple Myeloma.
Linares M, Hermouet S Front Immunol. 2022; 13:960829.
PMID: 35844583 PMC: 9281403. DOI: 10.3389/fimmu.2022.960829.